The role of glucagon-like peptide-1 receptor agonists (GLP1-RAs) in the management of the hypertensive patient with metabolic syndrome: a position paper from the Korean society of hypertension.
在代謝症候群高血壓患者管理中,胰高血糖素樣肽-1 受體激動劑 (GLP1-RAs) 的角色:來自韓國高血壓學會的立場文件。
Clin Hypertens 2024-08-31
Role of Glucagon-Like Peptide-1 Receptor Agonists in Achieving Weight Loss and Improving Cardiovascular Outcomes in People With Overweight and Obesity.
GLP-1受體激動劑在達到減重和改善超重和肥胖人群心血管結果中的作用。
J Am Heart Assoc 2023-08-01
Role of Glucagon-Like Peptide-1 Receptor Agonists on the Weight Loss of Individuals With Type 2 Diabetes: A Systematic Review.
糖尿病患者體重減輕的系統性回顧:葡萄糖樣肽-1受體激動劑的作用。
Cureus 2023-07-18
Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists on Body Weight and Cardiometabolic Parameters in Individuals With Obesity and Without Diabetes: A Systematic Review and Meta-Analysis.
肥胖且無糖尿病個體中胰高血糖素樣肽-1受體激動劑對體重和心臟代謝參數的功效和安全性:系統性回顧和荟萃分析。
Endocr Pract 2024-02-06
Glucagon-like peptide-1 receptor agonists modestly reduced blood pressure among patients with and without diabetes mellitus: A meta-analysis and meta-regression.
糖尿病患者和非糖尿病患者中,胰高血糖素樣肽-1受體激動劑對降低血壓有輕微效果:一項荟萃分析和荟萃回歸研究。
Diabetes Obes Metab 2024-05-08
The cardiovascular effects of GLP-1 receptor agonists beyond obesity and type 2 diabetes: An anti-atherosclerotic action.
GLP-1受體激動劑在肥胖和2型糖尿病之外對心血管的影響:抗動脈粥樣硬化作用。
Trends Cardiovasc Med 2024-04-23
Cardiovascular Benefits of GLP-1 Receptor Agonists in Patients Living with Obesity or Overweight: A Meta-analysis of Randomized Controlled Trials.
GLP-1 受體激動劑在肥胖或超重患者中的心血管益處:隨機對照試驗的荟萃分析。
Am J Cardiovasc Drugs 2024-05-15
Role of lifestyle and glucagon-like peptide-1 receptor agonists for weight loss in obesity, type 2 diabetes and steatotic liver diseases.
生活方式和胰高血糖素樣肽-1受體激動劑在肥胖症、2型糖尿病和脂肪肝疾病中減重的作用。
Aliment Pharmacol Ther 2024-05-30
Correlation Study of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) on Diabetic Patients with Hypertension.
GLP-1 受體激動劑 (GLP-1RAs) 與高血壓糖尿病患者之間的相關性研究。
Iran J Public Health 2024-08-01
Efficacy of Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists for Weight Loss Management in Non-Diabetic Patients.
非糖尿病患者使用胰高血糖素樣肽-1 (GLP-1) 受體激動劑進行減重管理的療效。
Cureus 2024-08-21
GLP-1-based therapies for the treatment of resistant hypertension in individuals with overweight or obesity: a review.
針對超重或肥胖個體的抗藥性高血壓治療的GLP-1基礎療法:一項綜述。
EClinicalMedicine 2024-09-09